tiprankstipranks
Trending News
More News >
Lite Strategy (LITS)
NASDAQ:LITS

Compare Lite Strategy (LITS) vs. Competitors

Compare
1,054 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Lite Strategy
$1.33
$52.58M
-1.09
-48.28%
ABVC BioPharma
$2.10
$49.09M
-9.05
266.61%
Jasper Therapeutics
$1.53
$42.82M
-0.26
-71.35%
5 Buy
2 Hold
0 Sell
Moderate Buy
Prelude Therapeutics
$2.45
$102.47M
-1.12
77.45%
Gain Therapeutics
$1.81
$69.62M
-2.83
-23.63%
4 Buy
0 Hold
0 Sell
Strong Buy
Estrella Immunopharma
$0.99
$41.78M
-2.69
-15.19%
0 Buy
0 Hold
0 Sell
Moderate Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
LITS
Lite Strategy
1.43
-1.40
-49.47%
ABVC
ABVC BioPharma
2.02
1.48
274.07%
JSPR
Jasper Therapeutics
1.53
-4.17
-73.16%
PRLD
Prelude Therapeutics
1.81
0.59
48.36%
GANX
Gain Therapeutics
1.81
-0.37
-16.97%
ESLA
Estrella Immunopharma
0.99
-0.17
-14.31%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts